44.03

1.32% -0.59

Boston Scientific Corp (BSX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Boston Scientific Corp stock is traded at $44.03, with a volume of 15.51M. It is down -1.32% in the last 24 hours and down -2.05% over the past month. Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Previous Close:

$44.62

Open:

$45.22

24h Volume:

15.51M

Relative Volume:

0.76

Market Cap:

$65.44B

Revenue:

$20.62B

Net Income/Loss:

$3.56B

P/E Ratio:

18.46

EPS:

2.3847

Net Cash Flow:

$3.48B

1W Performance:

-1.65%

1M Performance:

-2.05%

6M Performance:

-50.01%

1Y Performance:

-57.93%

1-Day Range:

$43.76

$45.25

1-Week Range:

$42.20

$45.45

52-Week Range:

$42.20

$109.50

Boston Scientific Corp Stock (BSX) Company Profile

Name

Boston Scientific Corp

Sector

Healthcare (1092)

Industry

Medical Devices (141)

Phone

508-683-4000

Address

300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA

Employee

59,000

Twitter

@bostonsci

Next Earnings Date

2026-07-29

Latest SEC Filings

BSX's Discussions on Twitter

Compare BSX vs ABT, SYK, MDT, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BSX Boston Scientific Corp	44.03	66.32B	20.62B	3.56B	3.48B	2.3847
ABT Abbott Laboratories	100.68	172.14B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	319.87	126.97B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	83.20	106.96B	36.36B	4.84B	5.43B	3.7261
EW Edwards Lifesciences Corp	85.73	50.58B	6.30B	1.07B	1.09B	1.8406

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-30-26	Downgrade	Raymond James	Strong Buy → Outperform
Oct-03-25	Downgrade	Erste Group	Buy → Hold
Sep-08-25	Upgrade	Oppenheimer	Perform → Outperform
Jun-16-25	Initiated	Leerink Partners	Outperform
Apr-16-25	Upgrade	Needham	Hold → Buy
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy
Feb-01-24	Upgrade	Mizuho	Neutral → Buy
Jul-19-23	Initiated	Robert W. Baird	Outperform
Jun-30-23	Initiated	CL King	Buy
May-30-23	Resumed	Morgan Stanley	Overweight
Mar-29-23	Initiated	UBS	Buy
Dec-22-22	Initiated	Mizuho	Neutral
Dec-20-22	Resumed	Citigroup	Buy
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Buy
Jul-06-22	Initiated	Wolfe Research	Outperform
May-27-22	Upgrade	Needham	Hold → Buy
Apr-13-22	Resumed	Truist	Buy
Mar-02-22	Resumed	BofA Securities	Buy
Dec-10-21	Initiated	RBC Capital Mkts	Outperform
May-26-21	Downgrade	Needham	Buy → Hold
May-25-21	Initiated	Barclays	Overweight
Apr-15-21	Initiated	Atlantic Equities	Overweight
Sep-17-20	Initiated	Truist	Buy
Sep-11-20	Initiated	Wolfe Research	Peer Perform
Apr-22-20	Downgrade	SVB Leerink	Outperform → Mkt Perform
Apr-01-20	Upgrade	Goldman	Neutral → Buy
Mar-05-20	Initiated	Citigroup	Buy
Feb-13-20	Initiated	Goldman	Neutral
Feb-06-20	Resumed	BTIG Research	Buy
Dec-30-19	Reiterated	Cowen	Outperform
Dec-19-19	Downgrade	Needham	Strong Buy → Buy
Sep-05-19	Resumed	JP Morgan	Overweight
Sep-03-19	Resumed	Barclays	Overweight
May-13-19	Upgrade	Evercore ISI	In-line → Outperform
Nov-28-18	Initiated	UBS	Buy
Oct-16-18	Initiated	Barclays	Overweight
Oct-02-18	Reiterated	Morgan Stanley	Overweight
Sep-07-18	Reiterated	Needham	Strong Buy
Sep-04-18	Upgrade	Jefferies	Hold → Buy
Jul-06-18	Reiterated	Needham	Strong Buy
Jun-27-18	Initiated	Bernstein	Outperform
Apr-26-18	Reiterated	Needham	Strong Buy

View All

Boston Scientific Corp Stock (BSX) Latest News

Jul 18, 2026

Boston Scientific stock trades steady as latest earnings highlight growth and margin focus - ad-hoc-news.de

Jul 18, 2026

The Bull Case For Boston Scientific (BSX) Could Change Following Global Recall Of CRE Endoscopy Devices - simplywall.st

Jul 18, 2026

Boston Scientific stock trades steady as cardiovascular and neuromodulation growth supports earnings - ad-hoc-news.de

Jul 18, 2026

Jul 17, 2026

Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch

Jul 17, 2026

Boston Scientific stock trades steadily as Q1 2026 growth and cardiology portfolio underpin valuatio - Ad Hoc News

Jul 17, 2026

Jul 16, 2026

Boston Scientific Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Jul 16, 2026

Boston Scientific Expands Medical Device R&D in Ireland With €75 Million Investment - Assembly Magazine

Jul 16, 2026

Jul 15, 2026

Boston Scientific (BSX): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance

Jul 15, 2026

Boston Scientific stock hits 52-week low at 42.24 USD By Investing.com - Investing.com South Africa

Jul 15, 2026

Boston Scientific stock hits 52-week low at 42.24 USD - Investing.com

Jul 15, 2026

Boston Scientific (BSX) Faces WATCHMAN Slowdown But Analysts Still See Upside - Yahoo Finance

Jul 15, 2026

Why Is Boston Scientific (NYSE:BSX) Growing Medical Technology? - Kalkine Media

Jul 15, 2026

Jul 14, 2026